VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
NUTXNutex Health, Inc.
$150.17$894M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksNUTXEarnings History

NUTX logoNutex Health, Inc. (NUTX) Earnings History

Earnings Pressure

16 years of earnings data (2010–2025) · 5-year EPS trend is negative

TTM Net Income
$96M
● Profitable
TTM EPS (Diluted)
$13.43
Per share, diluted
YoY EPS Growth
+7.9%
Solid
Net Margin
8.1%
After-tax profitability
EPS Growth Rate (CAGR)
1Y+7.9%
3YN/A
5Y-15.8%
10Y+74.3%
Operating Margin31.5%
Gross Margin50.8%
Return on Equity22.6%
Return on Assets9.0%
Record Annual Net Income$133MFY2021
Record Quarterly EPS$13.61Q3 2021
Consecutive Profitable Years2years
Q1 2026
Net Income$47M
EPS (Diluted)$6.52
YoY Growth+7.9%Solid
QoQ Growth+295.5%Excellent

Loading earnings history...

Nutex Health, Inc. (NUTX) Earnings Overview

As of June 23, 2026, Nutex Health, Inc. (NUTX) reported trailing twelve-month net income of $96M, reflecting +7.9% year-over-year growth. The company earned $13.43 per diluted share over the past four quarters, with a net profit margin of 8.1%.

Looking at the long-term picture, NUTX's 5-year EPS compound annual growth rate (CAGR) stands at -15.8%, signaling declining earnings. The company achieved its highest annual net income of $133M in fiscal 2021.

Nutex Health, Inc. maintains positive profitability with a gross margin of 50.8%, operating margin of 31.5%, and net margin of 8.1%. The company continues to generate positive earnings from operations. View revenue history →

Compared to peers including ADUS ($100M net income, 6.7% margin), AMSF ($46M net income, 14.9% margin), UHS ($1.52B net income, 8.6% margin), NUTX has outperformed on profitability metrics. Compare NUTX vs ADUS →

NUTX Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
NUTX logoNUTXCurrent
$96M$13.438.1%22.6%+7.9%—
ADUS logoADUS
$100M$5.406.7%9.3%+23.2%
AMSF logoAMSF
$46M$2.4614.9%18.5%-14.5%
UHS logoUHS
$1.5B-8.6%21.0%+37.3%
THC logoTHC
$1.7B$19.446.6%16.1%-52.6%
CYH logoCYH
-$88M$-0.654.1%-+196.7%
Best in group
Lowest in group

NUTX Historical Earnings Data (2010–2025)

13 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025$71M+35.7%$276M$10.488.1%31.5%
2024$52M+214.0%$131M$9.7110.9%27.2%
2023-$46M+89.2%-$32M$-10.39-18.5%-12.8%
2022-$425M-420.4%-$407M$-100.36-193.7%-185.4%
2021$133M+25.1%$170M$33.5540.0%51.4%
2020$106M+406.5%$153M$24.6938.7%55.9%
2019$21M+843.5%$35M$3.9821.6%35.8%
2018-$3M-583.5%-$2M$-0.39-3080.0%-2003.4%
2017$582,062+107.8%-$6M$0.141085.0%-10611.8%
2016-$7M-8968.1%$-448,600$-3.60--
2015$83,809+121.9%$-532,990$0.04--
2011$-383,393-342.4%$-844,577$-0.32-15.0%-33.1%
2010$158,137--$1M$0.1312.5%-106.3%

Download Data

Export NUTX earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

16+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

NUTX — Frequently Asked Questions

Quick answers to the most common questions about buying NUTX stock.

What is NUTX earnings per share (EPS)?

NUTX trailing twelve-month (TTM) diluted EPS is $13.43, reflecting +7.9% year-over-year growth. The 5-year EPS CAGR is -15.8%. Complete EPS history from 2010 to 2025 is available in the table on this page.

What is Nutex Health, Inc.'s net income?

Nutex Health, Inc. (NUTX) trailing twelve-month net income is $96M as of 2025. Earnings grew +7.9% year-over-year. Nutex Health, Inc. has been profitable for 2 consecutive years.

Is NUTX profitable?

Yes, NUTX is profitable with a TTM net income of $96M and a net profit margin of +8.1%. Nutex Health, Inc. has generated profits for 2 consecutive years.

What is NUTX's earnings growth rate?

NUTX compound annual EPS growth rates (CAGR): 1-Year: +7.9%, 3-Year: N/A, 5-Year: -15.8%, 10-Year: +74.3%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2010 to 2025.

What are NUTX's profit margins?

Nutex Health, Inc. net profit margin is +8.1%, operating margin is +31.5%, and gross margin is +50.8%. Margins are within a typical range for the sector. Return on Equity is +22.6%.

Is NUTX growing earnings?

NUTX is growing earnings steadily. YoY EPS growth of +7.9% is consistent with the 5-year CAGR of -15.8%. TTM net income is $96M.

What was NUTX's best earnings year?

Nutex Health, Inc.'s highest annual net income on record is $133M, achieved in fiscal year 2021. Earnings history on this page spans 2010 to 2025 and includes all annual and quarterly figures.

What were NUTX's earnings last quarter?

NUTX's most recent reported quarter was Q1 2026. Net income was $47M with diluted EPS of $6.52. For a full breakdown of all quarters, see the quarterly earnings table on this page.

NUTX Earnings Over Time (2010–2025)

Net income & EPS — annual and quarterly view